Clinical Trial Update: Safety and Efficacy of Extracorporeal Photopheresis (ECP) in the Treatment of Multiple Sclerosis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is assessing the safety and efficacy of Extracorporeal Photopheresis for Multiple Sclerosis, including Relapsing-Remitting and Second…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Progressive Multiple Sclerosis
• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Extracorporeal Photopheresis

Snippet

Sponsor: Abu Dhabi Stem Cells Center | Conditions: Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING